From about $63 on Aug. 18, the stock more than doubled the next day and has since climbed further. August ended at $140.34; September's advance has added roughly another 39% into Thursday's session, ...

Prestigious ESMO slot: Phase 3 melanoma data for Moderna’s intismeran autogene will be presented October 24 in a Presidential Symposium at ESMO 2026. Broad cancer program: Additional abstracts cover ...

Saeed bin Mubarak Al Hajeri, Minister of State, and Chairman of the Board of Directors of the Emirates Drug Establishment (EDE), held a meeting with Dr. Noubar Afeyan - Founder & CEO, Flagship ...

Moderna (MRNA) reached a 52-week high as CEO Bancel emphasized the company's mRNA platform capabilities beyond COVID vaccines, spotlighting cancer treatment.

Moderna (MRNA) stock hit a 52-week high after CEO Bancel said the company is an mRNA platform, not just a Covid vaccine maker ...

Moderna stock heads for its highest close since 2023 after CEO Stéphane Bancel says the drugmaker ‘has never been’ just a ...

Moderna (NASDAQ:MRNA) executives emphasized the company’s evolution beyond COVID-19 vaccines during a discussion with ...

Sanofi (Nasdaq: SNY) deprioritized its mRNA flu shot effort. But it is still vigorously defending its substantial share of the flu vaccine market, with its egg-grown Fluzone products and egg-free ...

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are rallying again as investors position ahead of a late-October data drop that could validate the first personalized cancer therapy tested at ...

A century-old building that once served as Moderna's Cambridge headquarters could be reborn as affordable housing, under a ...

Findings showed the study did not meet its primary endpoint of preventing CMV infection in seronegative participants. Vaccine efficacy against CMV infection was reported to be between 6% to 23% ...

Moderna Inc. stocks have been trading up by 13.31 percent after breakthrough vaccine data spurred strong investor optimism. Key Takeaways MRNA Traders Need Now FDA cleared Moderna’s updated 2026–2027 ...